2Razeghi E, Hadadi A, Mansor-Kiaei M, et al, Clinical Manifestation, Laboratory Findings, and the Response of Treatment in Kidney Transplant Recipients With CMV Infection[J]. Transplantation Proceedings, 2007,39(4):993-996.
4Marin LJ,Cunha AA,Aquino VH,et al. The use of qualitative and quantitative polymerase chain reactions for diagnosis of cytomegalovirus infections in bone marrow and kidey transplant recipients [J]. Rev Soe Bras Med Trop, 2004,37 (2) : 158-164.
5Roberts TC, Brennan DC, Buller RS, et al. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to Gancilovir therapy in renal transplant recipients[J]. J Infecl Dis, 1998,178 (3) : 626- 635.
7Bressollette Bodin C,Andre Garnier E,Robillard N ,et al. A multiparametric flow cytometry method for detection of modifications of antigen expression in polymorphonuclear cells infected hy human cytomegalovirus[J]. J Virol Methods, 2006,132 (1-2):32-39.
8Goossens, Christiaans, Blok, et al. Onset and duration ofcytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients [J]. J M Virol, 2004,72 (1) : 94- 101.
9Olderbrug N,Lam KM,Khan MA,et al. Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification[J]. Transplantation, 2000,70(8) : 1209-1215.
10Mengoli C,Cusinato R,Biasolo MA,et al. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection[J]. J M Virol, 2004,74 (1) : 78-84.
二级参考文献25
1Piiparinen H, Hockerstedt K, Lappalainen M, et al. Momitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplasnt patients[ J ]. J Clin Microbiol, 2002,40(8) : 2945-2952.
2Moil T, Moil S, Kanda Y, et al. Clinical significance of cytomegalovims(CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantaion [ J ]. Bone Marrow Transplant,2004,33(4) :431-434.
3Von Muller L, Hangol W, Hinz J, et al. High variability between results of different in-house tests for cytomegalovims monitoring and a standanlized quantitative plasma CMV PCR assay [ J ]. J Clin Microbiol, 2002, 40 (6) :2285-2287.
4Marin LI, Cunha AA, Aquino VH, et al. The use of qualitative and quantitative polymerase chain reactions for diagnosis of cytomegalovirus infections in bone marrow and kidey transplant recipients[J]. Rev Soc Bras Med Trop, 2004,37(2) : 158-164.
5Yakushiji K, Gondo H, Kamezaki K, et al. Momitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemla assay and quantitative real-time PCR [ J ]. Bone Marrow Transplant, 2002,29(7 ) : 599-606.
6Chen FH,Samson KT,Chen H, et al. Clinical applications of real-time PCR for diagnosis and treatment of human cytomegalovirus infection in children[ J]. Pediatr Allergy Immunol, 2004,15(3) : 210-215.
7Revello MG, Lillerl D, Zavattoni M, et al. Prenatal diagnosis of congenital human cytomegalovims infection in amniotic by nucleic acid sequence-based amplification assay[ J ]. J Clin Microbial, 2003,41 (4) : 1772-1774.
8Grejer AE, Verschuuren EA, Harmsen MC, et al. Direct quantificastion of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic sequence-based amplification [ J ]. J Clin Microbial, 2001,39( 1 ) : 251-259.
9Olderbrug N, Lain KM, Khan MA, et al. Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification[J]. Transplantation, 2000,70(8) : 1209-1215.
10Gratama JW, Comelissen JJ. Diagnostic potential of tetramca-based momitoring of cytomegalovims specific CD8^+ T lymphocyte in allogeneic stem cell transplantation[J]. Clin Immunol,2003,106( 1 ) :29-35.
